Reproductive rights and the state getting the birth control, RU-486, morning-after pills, and the Gardasil vaccine to the U.S. market /
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Údar corparáideach: | |
| Formáid: | Leictreonach Ríomhleabhar |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Santa Barbara, Calif. :
Praeger,
c2013.
|
| Sraith: | Reproductive rights and policy
|
| Ábhair: | |
| Rochtain ar líne: | An electronic book accessible through the World Wide Web; click to view |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Clár na nÁbhar:
- Introduction
- History of the FDA and drug regulation in the US
- The development of the pill
- U.S. pro-choice and pro-life groups' strategies since 1960
- Problems with Mifepristone (RU 486) and Misoprostol (Cytotec), 1988-2000
- The "Morning after pill," Plan B levonorgestrel formulation
- Reverse lobbying for Gardasil
- Conclusion--why a feminist historical institutionalist lens is important.